海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
- HIV-1 Infection
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, France, Germany, Mexico, Netherlands, Panama, Puerto Rico, Romania, Russian Federation, South Africa, Spain, Sweden, Taiwan, Thailand, United Kingdom, United States
- 2010-12-23
Not recruiting
- A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
- Hepatitis C, Chronic
- Australia, New Zealand, United States
- 2011-10-05
Recruiting
- Dasatinib plus Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
- Philadelphia Chromosone-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL)
- Australia, New Zealand
- 2007-11-28
Not Recruiting
- The Type 1 Diabetes Prevention Trial: Intranasal Insulin Trial II
- Type-1-Diabetes;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Australia, Germany, New Zealand
- 2010-05-05
Not Recruiting
- A clinical trial to study efficacy and safety of Fibrinogen compared to placebo in patients undergoing complex aortic surgeries.
- Complex Cardiovascular Surgery
- Austria, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, India, Italy, Japan, Poland, United Kingdom
- 2013-04-25
Not Recruiting
- A Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1 Infection (Endurance-1)
- HCV Genotype 1 and HCV Genotype 1/HIV-1 co-infected subjects MedDRA version: 18.1 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02];HCV Genotype 1 and HCV Genotype 1/HIV-1 co-infected subjects MedDRA version: 18.1 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02];HCV Genotype 1 and HCV Genotype 1/HIV-1 co-infected subjects MedDRA version: 18.1 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Austria, Belgium, Canada, Chile, Germany, Hungary, Israel, Korea, Republic of, Lithuania, Mexico, New Zealand, Poland, Portugal, Puerto Rico, Russian Federation, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2015-08-19
Authorised
- Phase 3a study to evaluate the efficacy and safety of 4-week treatment of the axillary skin with 1% GPB cream vs placebo and open-label Phase 3b study to assess long-term efficacy and safety in patients with primary axillary hyperhidrosis treated with 1% GPB cream
- Moderate to severe primary axillary hyperhidrosis MedDRA version: 20.0 Level: PT Classification code 10020642 Term: Hyperhidrosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Denmark, Germany, Hungary, Poland, Sweden, United Kingdom
- 2018-09-27
Not recruiting
- Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders
- Heterozygous Familial Hypercholesterolemia
- Australia, Austria, Belgium, Brazil, Canada, Colombia, Czech Republic, Czechia, Finland, Greece, Hungary, Italy, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovenia, South Africa, Spain, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2015-02-25
Not recruiting
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
- Hematological Malignancy
- Argentina, Austria, Belgium, Brazil, Chile, Finland, France, Greece, Israel, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, Ukraine, United Kingdom, United States
- 2010-03-09
Authorised
- A new therapeutic approach to prevent acute complications in type 2 diabetes: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® against the cOnventional insulin therapy: GALILEO
- diabetes mellitus type 2, inadequate metabolic control, indication for insulin therapy myocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-function, endothelial dysfunction MedDRA version: 14.1 Level: PT Classification code 10012607 Term: Diabetes mellitus inadequate control System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: PT Classification code 10012689 Term: Diabetic retinopathy System Organ Class: 10015919 - Eye disorders MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders MedDRA version: 14.1 Level: HLT Classification code 10012654 Term: Diabetic complications cardiovascular System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: PT Classification code 10012647 Term: Diabetic cardiomyopathy System Organ Class: 10007541 - Cardiac disorders MedDRA version: 14.1 Level: HLT Classification code 10012658 Term: Diabetic complications renal System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: HLT Classification code 10012657 Term: Diabetic complications ophthalmic System Organ Class: 10014698 - Endocrine disorders MedDRA version: 14.1 Level: PT Classification code 10054044 Term: Diabetic microangiopathy System Organ Class: 10047065 - Vascular disorders MedDRA version: 14.1 Level: HLGT Classification code 10012653 Term: Diabetic complications System Organ Class: 10014698 - Endocrine disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria
- 2012-04-17
